Bayesian Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26,602	Closed	-$4.04M	–	585
2025 Q2	$4.04M	Buy	+26,602	New	+$3.55M	0.64%	32
2025 Q1	–	Sell	-17,965	Closed	-$3.32M	–	669
2024 Q4	$3.32M	Buy	+17,965	New	+$3.46M	0.41%	63
2024 Q3	–	Sell	-2,430	Closed	-$502K	–	745
2024 Q2	$502K	Buy	+2,430	New	+$551K	0.06%	368
2024 Q1	–	Sell	-870	Closed	-$206K	–	830
2023 Q4	$206K	Buy	+870	New	+$171K	0.02%	596
2023 Q3	–	Sell	-1,300	Closed	-$273K	–	745
2023 Q2	$273K	Buy	+1,300	New	+$259K	0.03%	562
2023 Q1	–	Sell	-7,100	Closed	-$1.55M	–	845
2022 Q4	$1.55M	Buy	+7,100	New	+$1.55M	0.23%	97
2020 Q3	–	Sell	-6,100	Closed	-$1.06M	–	545
2020 Q2	$1.06M	Sell	6,100 -2,700	-31%	-$431K	0.23%	119
2020 Q1	$1.11M	Buy	+8,800	New	+$1.32M	0.24%	104
2019 Q3	–	Sell	-2,128	Closed	-$302K	–	543
2019 Q2	$302K	Sell	2,128 -2,700	-56%	-$366K	0.06%	356
2019 Q1	$701K	Buy	+4,828	New	+$634K	0.13%	216
2017 Q2	–	Sell	-6,566	Closed	-$591K	–	456
2017 Q1	$591K	Buy	+6,566	New	+$558K	0.28%	123